Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers

Background. Results from clinical studies suggest that the dihydropyridine calcium channel blocker (d-CCB) lercanidipine may be associated with a lower incidence of peripheral edema than are older d-CCBs. Aim. To conduct a meta-analysis of published data from randomized controlled trials (RCTs) to a...

Celý popis

Podrobná bibliografie

Hlavní autoři:	K. Makarounas-Kirchmann, S. Glover-Koudounas, P. Ferrari
Médium:	Artigo
Jazyk:	Russo
Vydáno:	«SILICEA-POLIGRAF» LLC 2010-12-01
Edice:	Кардиоваскулярная терапия и профилактика
Témata:	calcium channel blockers dihydropyridines lercanidipine edema adverse events tolerability
On-line přístup:	https://cardiovascular.elpub.ru/jour/article/view/2146
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!